ArticleCell reports. Medicine2023

Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management.

Andrea I d'Aquino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.